Terns Pharmaceuticals Inc share price logo

Terns Pharmaceuticals Inc

NASDAQ: TERN

Mid Cap

$52.97

+0.04

(+0.08%)

as on

Terns Pharmaceuticals Inc Stock Performance

as on May 5, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $52.94
    $52.98
    downward going graph

    0.06%

    Downside

    0.02%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.66
    $53.19
    downward going graph

    94.99%

    Downside

    0.42%

    Upside

    downward going graph

Terns Pharmaceuticals Inc share price movements today

Previous Close
$52.93
Open
$52.96
Volume
3.0M
Day's Low - High
$52.94 - $52.98
52 Week Low - High
$2.66 - $53.19

Terns Pharmaceuticals Inc Historical Returns

1 Month Return
+ 0.4 %
3 Month Return
+ 49.77 %
1 Year Return
+ 1503.94 %
3 Year Return
+ 324.8 %
5 Year Return
+ 210.44 %

Terns Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Terns Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.1B

EPS (TTM)

-1.1489

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-110.0M

Revenue (TTM)

1.0M

Profit Margin

0.00%

Return On Equity TTM

-14.23%

Terns Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Terns Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$6.1B210.44%NA0.00%
BUY$39.5B123.19%74.5912.55%
BUY$107.8B98.21%27.7132.94%
NA$32.7BNA118.975.37%
BUY$73.5B45.4%17.1229.65%

Stock Returns calculator for Terns Pharmaceuticals Inc Stock including INR - Dollar returns

The Terns Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Terns Pharmaceuticals Inc investment value today

Current value as on today

₹18,10,283

Returns

₹17,10,283

(+1.71K%)

Returns from Terns Pharmaceuticals Inc Stock

₹15,05,152 (+1.51K%)

Dollar Impact

₹2,05,132 (+205.13%)

Analyst Recommendation on Terns Pharmaceuticals Inc Stock

Based on 14 analysts

BUY

78.57%

Buy

21.43%

Hold

0.00%

Sell

Based on 14 analysts, 78.57% of analysts recommend a 'BUY' rating for Terns Pharmaceuticals Inc. Average target price of $53

Terns Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Terns Pharmaceuticals Inc.

What analysts predicted

0.06%UPSIDE

Target Price

$53

Current Price

$52.97

Analyzed by

14 Analysts

Target

$53.00

Terns Pharmaceuticals Inc target price $53, a slight upside of 0.06% compared to current price of $52.97. According to 14 analysts rating.

Terns Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Terns Pharmaceuticals Inc Stock has decreased by -52% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-52% versus previous 30 day period

Terns Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
1
-
-
-
-
-
-
-
-
Gross Profit
0
1
0
0
-
-
-
0
-
0
Operating Income
-33
-24
-25
-25
-24
-25
-27
-27
-27
-27
EBITDA
-32
-23
-25
-25
-24
-25
-27
-23
-24
-34
Interest Expense
-
2
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-29
-20
-22
-22
-21
-21
-23
-24
-24
-23
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-29
-21
-22
-22
-21
-21
-23
-24
-24
-23
Net Profit Margin
0.00%
-1589.94%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Terns Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
1
-
-
-
-
Gross Profit
0
0
0
1
-1
0
-
-
Operating Income
-18
-70
-37
-49
-62
-102
-101
-110
EBITDA
-18
-68
-36
-49
-60
-101
-100
-110
Interest Expense
-
1
2
0
2
-
-
-
Depreciation
0
0
0
0
1
0
0
0
Income Before Tax
-18
-68
-29
-49
-59
-89
-88
-95
Income Tax Expense
0
0
0
0
0
0
0
0
Net Income
-17
-68
-29
-50
-60
-90
-88
-96
Net Profit Margin
0.00%
0.00%
0.00%
-5015.80%
0.00%
0.00%
0.00%
0.00%

Terns Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-21
-22
-22
-21
-21
-23
-24
-24
-23
Operating Cash Flow
-19
-22
-16
-16
-14
-24
-18
-19
-19
Investing Cash Flow
47
7
42
31
-94
1
25
24
-350
Financing Cash Flow
13
-
0
163
0
0
0
-
743
Change in Cash
42
-14
26
178
-108
-22
6
4
374

Terns Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-68
-40
-50
-60
-90
-88
-96
Operating Cash Flow
-66
-29
-41
-49
-67
-70
-82
Investing Cash Flow
-3
6
-119
-22
-37
-12
-298
Financing Cash Flow
0
85
134
167
41
163
743
Change in Cash
-70
62
-27
95
-63
81
363

Global Institutional Holdings in Terns Pharmaceuticals Inc

Funds
Holdings
Orbimed Advisors, LLC
6.95%
Vestal Point Capital LP
3.9%
venBio Select Advisor LLC
3.77%
Citadel Advisors Llc
2.74%
Schonfeld Strategic Advisors LLC
3.49%

Terns Pharmaceuticals Inc News & Key Events

  • img

    Today's Timeline - 25 March

    Wed, 10:08 PM

    -

    Merck agrees to acquire Terns for $53 per share, valuing it at $6.7 billion, shares rise 5%.

Insights on Terns Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, TERN has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, TERN stock has moved up by 1503.9%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, TERN has outperformed top 5 stocks with highest market-cap in its industry

About Terns Pharmaceuticals Inc

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1/2 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced metabolic stability and liver distribution that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-801 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
OrganisationTerns Pharmaceuticals Inc
Headquarters1065 East Hillsdale Boulevard, Foster City, CA, United States, 94404
IndustryBiotechnology
CEOMs. Amy L. Burroughs M.B.A.
E-voting on sharesClick here to vote

Key Management of Terns Pharmaceuticals Inc

Name

Title

Ms. Debra Sieminski

Senior Vice President of Medical Affairs

Ms. Amy L. Burroughs M.B.A.

CEO & Director

Mr. Andrew W. Gengos

CFO & Head of Corporate Development

Mr. Scott Harris

Chief Development & Operations Officer

Ms. Theresa Clouser

Vice President of Marketing

Ms. Robin Andrulevich

Chief People Officer

Ms. Melita Sun Jung

Chief Business Officer

Dr. Emil T. Kuriakose M.D.

Chief Medical Officer

Ms. Caryn Gordon McDowell J.D.

Chief Legal Officer

Dr. Jeffrey R. Jasper Ph.D.

SVP & Senior Distinguished Research Fellow

FAQs

What is Terns Pharmaceuticals Inc share price today?

Terns Pharmaceuticals Inc share price today is $52.97 as on at the close of the market. Terns Pharmaceuticals Inc share today touched a day high of $52.98 and a low of $52.94.

What is the 52 week high and 52 week low for Terns Pharmaceuticals Inc share?

Terns Pharmaceuticals Inc share touched a 52 week high of $53.19 on and a 52 week low of $2.66 on . Terns Pharmaceuticals Inc stock price today i.e. is closed at $52.97,which is 0.41% down from its 52 week high and 1895.10% up from its 52 week low.

What is Terns Pharmaceuticals Inc's market capitalisation today?

Terns Pharmaceuticals Inc market capitalisation is $0.01T as on .

How to invest in Terns Pharmaceuticals Inc Stock (TERN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Terns Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Terns Pharmaceuticals Inc Shares that will get you 0.0283 shares as per Terns Pharmaceuticals Inc share price of $52.97 per share as on May 5, 2026 at 1:29 am IST.

What is the minimum amount required to buy Terns Pharmaceuticals Inc Stock (TERN) from India?

Indian investors can start investing in Terns Pharmaceuticals Inc (TERN) shares with as little as ₹95.067 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹950.67 in Terns Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Terns Pharmaceuticals Inc share’s latest price of $52.97 as on May 5, 2026 at 1:29 am IST, you will get 0.1888 shares of Terns Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Terns Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Terns Pharmaceuticals Inc stock has given 210.44% share price returns and 28.65% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?